Georgia's Online Cancer Information Center

Prostate Cancer Clinical Trials in Georgia

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Cancer Type = Prostate Cancer
Cancer Type = Prostate Cancer
There are currently 24 active Prostate Cancer clinical trials in Georgia.
2.
A Phase 1 Multiple-Dose Study to Evaluate the Safety and Tolerability of XmAb®22841 Monotherapy and in Combination With Pembrolizumab in Subjects With Selected Advanced Solid Tumors (DUET-4)
Cancer Type
Breast Cancer, Cervical Cancer, Colon/Rectal Cancer, Eye Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Melanoma, Pancreatic Cancer, Prostate Cancer , Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Unknown Primary
NCT ID
NCT03849469
Protocol IDs
XmAb22841-01
NCI-2019-02498
DUET-4
Treatment Sites (2)
Emory University Hospital - Midtown
Atlanta
Scott Edelman
404-686-4411
Winship Cancer Institute of Emory University
Atlanta
Scott Edelman
404-778-5180
3.
A Phase 1 Study of ASP1951 in Subjects With Advanced Solid Tumors
Cancer Type
Lung Cancer, Prostate Cancer , Unknown Primary
NCT ID
NCT03799003
Protocol IDs
1951-CL-0101
NCI-2019-02414
Treatment Sites (1)
4.
NCORP Trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Cancer Type
Prostate Cancer , Unknown Primary
NCT ID
NCT03706365
Protocol IDs
16598
NCI-2019-00897
I3Y-MC-JPCM
2016-004276-21
Treatment Sites (13)
Atlanta Cancer Care - Alpharetta
Alpharetta
Kristin Sieverding
770-777-1315
Atlanta Cancer Care - Conyers
Conyers
404-303-3355
Atlanta Cancer Care - Cumming
Cumming
Renee Gaiter
770-205-5292 x1041
Atlanta Cancer Care - Decatur
Decatur
404-303-3355
Atlanta Cancer Care - Stockbridge
Jonesboro
Andrena Jefferson
678 466-2069
Atlanta Cancer Care - Tower
Atlanta
404-303-3355
Georgia Cancer Specialists - Athens
Athens
Cynthia Pirkle
Georgia Cancer Specialists - CenterPointe
Sandy Springs
Anila Lokhandwala
404-256-4777 ext 9242
Georgia Cancer Specialists - Macon-Coliseum
Macon
Sonia Hernandez
478-745-6130 x8152
Georgia Cancer Specialists - Stemmer
Decatur
Nina Patel
770-496-5555
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
5.
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Cancer Type
Prostate Cancer , Unknown Primary
NCT ID
NCT03395197
Protocol IDs
C3441021
NCI-2018-01651
TALAPRO-2
2017-003295-31
Treatment Sites (5)
Piedmont Cancer Institute - Atlanta
Atlanta
Katie Adams
678-298-3238
Piedmont Cancer Institute - Fayetteville
Fayetteville
678-298-3238
Piedmont Cancer Institute - Newnan
Newnan
Katie Adams
678-298-3238
Piedmont Cancer Institute - Stockbridge
Stockbridge
Katie Adams
678-298-3238
6.
A Phase II Study of Nivolumab Combined with Ipilimumab for Patients with Advanced Rare Genitourinary Tumors
Cancer Type
Adrenal Cancer, Bladder Cancer, Germ Cell Tumor, Penile Cancer, Prostate Cancer
NCT ID
NCT03333616
Protocol IDs
17-423
NCI-2018-00182
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
Scott Edelman
404-778-5180
9.
A Randomized Controlled Trial of ProstAtak® as Adjuvant to Up-front Radiation Therapy For Localized Prostate Cancer
Cancer Type
Prostate Cancer
NCT ID
NCT01436968
Protocol IDs
PrTK03
NCI-2012-01912
Treatment Sites (1)
Atlanta VA Medical Center
Decatur
Scott Edelman
404-728-7680
12.
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects With High-risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Cancer Type
Prostate Cancer , Unknown Primary
NCT ID
NCT03767244
Protocol IDs
CR108535
NCI-2019-04921
2018-001746-34
56021927PCR3011
2018-001746-34
Treatment Sites (2)
13.
NCORP Trial
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors
Cancer Type
Breast Cancer, Cervical Cancer, Lymphoma, Prostate Cancer
NCT ID
NCT03190291
Protocol IDs
WF-30917CD
WF-30917CD
WF-30917CD
NCI-2017-01840
Treatment Sites (1)
14.
Advanced PET-CT Directed Post-Prostatectomy Radiotherapy to Enhance Prostate Cancer Outcomes
Cancer Type
Prostate Cancer
NCT ID
NCT03762759
Protocol IDs
RAD4516-18
NCI-2018-02702
IRB00106863
Treatment Sites (3)
15.
Cabazitaxel with Abiraterone versus Abiraterone Alone Randomized Trial for Extensive Disease following Docetaxel: The CHAARTED2 Trial
Cancer Type
Prostate Cancer , Unknown Primary
NCT ID
NCT03419234
Protocol IDs
EA8153
EA8153
NCI-2017-00389
Treatment Sites (2)
17.
Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer
Cancer Type
Prostate Cancer
NCT ID
NCT02766478
Protocol IDs
EU3129-15
NCI-2016-00400
IRB00086186
Treatment Sites (1)
18.
Improving Health Literacy in African-American Prostate Cancer Patients
Cancer Type
Prostate Cancer
NCT ID
NCT03322891
Protocol IDs
HU-HEALTHLITERACY
NCI-2018-00842
IRB00091879
IRB00085616
Treatment Sites (4)
19.
Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy
Cancer Type
Prostate Cancer
NCT ID
NCT03860961
Protocol IDs
NRG-CC007CD
NRG-CC007CD
NRG-CC007CD
NCI-2019-00794
Treatment Sites (1)
Augusta University Medical Center
Augusta
Carol Terry
706-721-4430
20.
Investigation of Therapy Response with Amino Acid Analogue Transport PET Imaging
Cancer Type
Prostate Cancer
NCT ID
NCT02830880
Protocol IDs
RAD2786-14
NCI-2015-01105
IRB00073616
Treatment Sites (1)
21.
NCORP Trial
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Cancer Type
Prostate Cancer
NCT ID
NCT03367702
Protocol IDs
NRG-GU005
NRG-GU005
NCI-2017-01398
Treatment Sites (7)
23.
NCORP Trial
Phase II-III Trial of Adjuvant Radiotherapy following Radical Prostatectomy with or without Adjuvant Docetaxel
Cancer Type
Prostate Cancer
NCT ID
NCT03070886
Protocol IDs
NRG-GU002
NRG-GU002
NCI-2016-00963
NRG-GU002
Treatment Sites (1)
24.
Validation of FACBC as an Early Indicator of Sub-clinical Metastatic Disease among High-Risk Prostate Cancer Patients with Presumed Localized Disease
Cancer Type
Prostate Cancer
NCT ID
NCT03081884
Protocol IDs
EU3330-16
NCI-2017-00251
IRB00092595
Treatment Sites (3)
Emory University Hospital - Midtown
Atlanta
Scott Edelman
404-686-4411
Winship Cancer Institute of Emory University
Atlanta
Scott Edelman
404-778-5180
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.